Search research articles
Contact Us
Filters
Showing results (31-40 of 84) with videos related to
Page
of 9
Sort By:
Plos One
|
February 20, 2020
Validating indicators of CNS disorders in a swine model of neurological disease
Vicki J Swier, Katherine A White, David K Meyerholz, et al.
Geroscience
|
January 25, 2022
Phosphorylation-dependent proteome of Marcks in ependyma during aging and behavioral homeostasis in the mouse forebrain
Nagendran Muthusamy, Taufika I Williams, Ryan O'Toole, et al.
Plos One
|
May 3, 2017
A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies
Ryan D Geraets, Logan M Langin, Jacob T Cain, et al.
Orphanet Journal of Rare Diseases
|
January 23, 2019
Tracking sex-dependent differences in a mouse model of CLN6-Batten disease
McKayla J Poppens, Jacob T Cain, Tyler B Johnson, et al.
Neurobiology of Disease
|
January 18, 2006
Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons
Jill M Weimer, Andrew W Custer, Jared W Benedict, et al.
Journal of Neurodevelopmental Disorders
|
May 7, 2011
Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia
Sheryl S Moy, H Troy Ghashghaei, Randal J Nonneman, et al.
JIMD Reports
|
June 21, 2018
Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis)
Erika F Augustine, Christopher A Beck, Heather R Adams, et al.
Aging Cell
|
May 27, 2015
MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging
Nagendran Muthusamy, Laura J Sommerville, Adam J Moeser, et al.
Plos One
|
August 8, 2018
Searching for novel biomarkers using a mouse model of CLN3-Batten disease
Derek Timm, Jacob T Cain, Ryan D Geraets, et al.
Biomolecules
|
August 26, 2023
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification
Ian Keyzor, Simon Shohet, Jeff Castelli, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 84) with videos related to
Sort By:
Page
of 9
Plos One
|
February 20, 2020
Validating indicators of CNS disorders in a swine model of neurological disease
Vicki J Swier, Katherine A White, David K Meyerholz, et al.
Geroscience
|
January 25, 2022
Phosphorylation-dependent proteome of Marcks in ependyma during aging and behavioral homeostasis in the mouse forebrain
Nagendran Muthusamy, Taufika I Williams, Ryan O'Toole, et al.
Plos One
|
May 3, 2017
A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies
Ryan D Geraets, Logan M Langin, Jacob T Cain, et al.
Orphanet Journal of Rare Diseases
|
January 23, 2019
Tracking sex-dependent differences in a mouse model of CLN6-Batten disease
McKayla J Poppens, Jacob T Cain, Tyler B Johnson, et al.
Neurobiology of Disease
|
January 18, 2006
Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons
Jill M Weimer, Andrew W Custer, Jared W Benedict, et al.
Journal of Neurodevelopmental Disorders
|
May 7, 2011
Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia
Sheryl S Moy, H Troy Ghashghaei, Randal J Nonneman, et al.
JIMD Reports
|
June 21, 2018
Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis)
Erika F Augustine, Christopher A Beck, Heather R Adams, et al.
Aging Cell
|
May 27, 2015
MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging
Nagendran Muthusamy, Laura J Sommerville, Adam J Moeser, et al.
Plos One
|
August 8, 2018
Searching for novel biomarkers using a mouse model of CLN3-Batten disease
Derek Timm, Jacob T Cain, Ryan D Geraets, et al.
Biomolecules
|
August 26, 2023
Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification
Ian Keyzor, Simon Shohet, Jeff Castelli, et al.
Page
of 9